Business Description
Myomo Inc
NAICS : 334510
SIC : 3842
ISIN : US62857J2015
Total Employee Number:
195Description
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.83 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 2.11 | |||||
Debt-to-EBITDA | -1.55 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -3.26 | |||||
Beneish M-Score | -1.66 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.7 | |||||
3-Year EBITDA Growth Rate | 40.5 | |||||
3-Year EPS without NRI Growth Rate | 37.8 | |||||
3-Year FCF Growth Rate | 33.8 | |||||
3-Year Book Growth Rate | -28.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 43.17 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 17.57 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.58 | |||||
9-Day RSI | 45.16 | |||||
14-Day RSI | 47.48 | |||||
3-1 Month Momentum % | 101.04 | |||||
6-1 Month Momentum % | 39.52 | |||||
12-1 Month Momentum % | -36.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.73 | |||||
Quick Ratio | 2.36 | |||||
Cash Ratio | 1.67 | |||||
Days Inventory | 92.68 | |||||
Days Sales Outstanding | 45.94 | |||||
Days Payable | 51.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -70.6 | |||||
Shareholder Yield % | -27.11 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 65.96 | |||||
Operating Margin % | -34.07 | |||||
Net Margin % | -36.69 | |||||
EBITDA Margin % | -29.73 | |||||
FCF Margin % | -41.89 | |||||
OCF Margin % | -34.22 | |||||
ROE % | -101.69 | |||||
ROA % | -39.99 | |||||
ROIC % | -75.47 | |||||
3-Year ROIIC % | -26.44 | |||||
ROC (Joel Greenblatt) % | -125.08 | |||||
ROCE % | -51.41 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.12 | |||||
PB Ratio | 4.72 | |||||
Price-to-Tangible-Book | 5.91 | |||||
EV-to-EBIT | -3.21 | |||||
EV-to-EBITDA | -3.74 | |||||
EV-to-Forward-EBITDA | -4.92 | |||||
EV-to-Revenue | 1.11 | |||||
EV-to-Forward-Revenue | 1.01 | |||||
EV-to-FCF | -2.66 | |||||
Price-to-GF-Value | 0.35 | |||||
Earnings Yield (Greenblatt) % | -31.15 | |||||
FCF Yield % | -40.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Myomo Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 35.409 | ||
| EPS (TTM) (€) | -0.31 | ||
| Beta | 3.8802 | ||
| 3-Year Sharpe Ratio | 0.63 | ||
| 3-Year Sortino Ratio | 1.75 | ||
| Volatility % | 70.67 | ||
| 14-Day RSI | 47.48 | ||
| 14-Day ATR (€) | 0.05362 | ||
| 20-Day SMA (€) | 1.01625 | ||
| 12-1 Month Momentum % | -36.86 | ||
| 52-Week Range (€) | 0.554 - 1.862 | ||
| Shares Outstanding (Mil) | 38.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Myomo Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Myomo Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-10 16:30 | In 119 days | ||
| Third quarter earnings results for 2026 | 2026-11-10 | In 118 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-11 16:30 | In 28 days | ||
| Second quarter earnings results for 2026 | 2026-08-11 | In 27 days | ||
| General meeting for 2026 | 2026-06-25 09:00 | 1.03 (+0.00%) | ||
| iAccess Alpha Virtual Best Ideas Summer Investment Conference | 2026-06-23 13:00 | 1.12 (+2.38%) | ||
| Sidoti’s Virtual Micro Cap Conference | 2026-05-21 13:45 | 0.74 (+0.00%) | ||
| Alliance Global Partners Annual Healthcare Company Showcase | 2026-05-20 11:20 | 0.76 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 16:30 | 0.74 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 0.74 (+0.00%) |
Show
Entries
Myomo Inc Frequently Asked Questions
What is Myomo Inc(FRA:0M61)'s stock price today?
The current price of FRA:0M61 is €0.95. The 52 week high of FRA:0M61 is €1.86 and 52 week low is €0.55.
When is next earnings date of Myomo Inc(FRA:0M61)?
The next earnings date of Myomo Inc(FRA:0M61) is 2026-08-11 Est..
Does Myomo Inc(FRA:0M61) pay dividends? If so, how much?
Myomo Inc(FRA:0M61) does not pay dividend.
Press Release
Articles on Myomo Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers